LXRX Research and Charts

LXRX - Lexicon Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2020-02-03 (Delayed quote data 2025-04-04)

Last 0.42	Change ⇓ -0.08 (0.00%)	Volume 10,928,209
	Open 0.41	High 0.46	Low 0.41

8EMA (Daily) 0.44	40EMA (Daily) 0.51	50EMA (Daily) 0.55	STO (Daily) 41.876	MACD Hist (Daily) 0.045
8EMA (Weekly) 0.528	40EMA (Weekly) 1.04	50EMA (Weekly) 1.15	STO (Weekly) 15.443	MACD Hist (Weekly) -0.010


Company Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.